Literature DB >> 27541955

Prostate Cancer Incidence Rates 2 Years After the US Preventive Services Task Force Recommendations Against Screening.

Ahmedin Jemal1, Jiemin Ma1, Rebecca Siegel1, Stacey Fedewa1, Otis Brawley2, Elizabeth M Ward3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27541955     DOI： 10.1001/jamaoncol.2016.2667

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  29 in total

1.  Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.

Authors:  Daniel M Frendl; Mara M Epstein; Hassan Fouayzi; Richard Krajenta; Benjamin A Rybicki; Mitchell H Sokoloff
Journal:  Cancer Causes Control       Date:  2020-06-17       Impact factor: 2.506

Review 2.  The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA.

Authors:  Katherine Fleshner; Sigrid V Carlsson; Monique J Roobol
Journal:  Nat Rev Urol       Date:  2016-12-20       Impact factor: 14.432

3.  Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.

Authors:  Jim C Hu; Paul Nguyen; Jialin Mao; Joshua Halpern; Jonathan Shoag; Jason D Wright; Art Sedrakyan
Journal:  JAMA Oncol       Date:  2017-05-01       Impact factor: 31.777

4.  Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.

Authors:  Scott P Kelly; William F Anderson; Philip S Rosenberg; Michael B Cook
Journal:  Eur Urol Focus       Date:  2017-11-20

5.  Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right?

Authors:  Izak Faiena; Stuart Holden; Mathew R Cooperberg; Stuart Holden; Howard R Soule; Jonathan W Simons; Todd M Morgan; David F Penson; Alicia K Morgans; Maha Hussain
Journal:  J Clin Oncol       Date:  2018-02-05       Impact factor: 44.544

6.  The Impact of Massachusetts Health Reform on Colorectal and Breast Cancer Stage at Diagnosis.

Authors:  Lindsay M Sabik; Kirsten Y Eom; Bassam Dahman; Jie Li; Nengliang Yao; G J van Londen; Cathy J Bradley
Journal:  Med Care       Date:  2020-02       Impact factor: 2.983

7.  Contemporary Incidence and Outcomes of Prostate Cancer Lymph Node Metastases.

Authors:  Adrien N Bernstein; Jonathan E Shoag; Ron Golan; Joshua A Halpern; Edward M Schaeffer; Wei-Chun Hsu; Paul L Nguyen; Art Sedrakyan; Ronald C Chen; Scott E Eggener; Jim C Hu
Journal:  J Urol       Date:  2017-12-26       Impact factor: 7.450

8.  Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.

Authors:  Jun Li; David A Siegel; Jessica B King
Journal:  Ann Epidemiol       Date:  2018-03-06       Impact factor: 3.797

9.  Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.

Authors:  Ahmedin Jemal; MaryBeth B Culp; Jiemin Ma; Farhad Islami; Stacey A Fedewa
Journal:  J Natl Cancer Inst       Date:  2021-01-04       Impact factor: 13.506

10.  Prostate-specific antigen testing for prostate cancer screening: A national survey of Canadian primary care physicians' opinions and practices.

Authors:  Mitchell Geoffrey Goldenberg; Sean C Skeldon; Madhur Nayan; Yegappan Suppiah; Linda Chow; Elise Fryml; David Greenberg; Rajiv K Singal; S Larry Goldenberg
Journal:  Can Urol Assoc J       Date:  2017-11-01       Impact factor: 1.862
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.